Trial Profile
Pegfilgrastim Versus Filgrastim - Intraindividual Comparison of Quantity and Quality of Mobilized Peripheral Blood Stem Cells in Patients With Non Hodgkin-lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary) ; Cisplatin; Epirubicin; Etoposide; Filgrastim; Ifosfamide; Rituximab
- Indications Non-Hodgkin's lymphoma; Stem cell mobilisation
- Focus Therapeutic Use
- 17 Oct 2014 New trial record